Decheng Capital LLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 2010850 MENLO PARK, CA

Position in PYXS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$477,142

+$101,311 QoQ

Shares Held

326,810

0.0% QoQ

Ownership

0.516%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#14

of 78 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Decheng Capital LLC holds $647,433,708 across 13 Biotechnology names. PYXS ranks #13 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGON	CG Oncology, Inc.	6,371,669	$431,234,557
2	NUVB	Nuvation Bio Inc.	25,954,439	$111,344,543
3	UPB	Upstream Bio, Inc.	2,724,868	$24,523,812
4	ACRS	Aclaris Therapeutics, Inc.	4,041,736	$15,156,510
5	AARD	Aardvark Therapeutics, Inc.	3,917,299	$14,768,217
6	NAMS	NewAmsterdam Pharma Co N.V.	325,057	$10,405,074
7	RCUS	Arcus Biosciences, Inc.	477,819	$10,320,890
8	RVMD	Revolution Medicines, Inc.	93,500	$9,092,875

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$477,142	326,810	0.0%	Shares	Sole	2026-05-13
2025-12-31	$375,831	326,810	0.0%	Shares	Sole	2026-02-12
2025-09-30	$725,518	326,810	0.0%	Shares	Sole	2025-11-14
2025-06-30	$359,491	326,810	0.0%	Shares	Sole	2025-08-13
2025-03-31	$320,273	326,810	0.0%	Shares	Sole	2025-05-08
2024-12-31	$509,823	326,810	0.0%	Shares	Sole	2025-02-14
2024-09-30	$1,199,392	326,810	0.0%	Shares	Sole	2024-11-15
2024-06-30	$1,081,741	326,810	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,392,210	326,810	0.0%	Shares	Sole	2024-05-14
2023-12-31	$588,258	326,810	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.